Trials / Conditions / Mixed Hyperlipidemia

Mixed Hyperlipidemia

10 registered clinical trials studyying Mixed Hyperlipidemia.

Status	Trial	Sponsor	Phase
Completed	Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With Hypercholesterolemia NCT04885218	Jiangsu HengRui Medicine Co., Ltd.	Phase 3
Completed	A Pilot Study to Evaluate the Lipid Effects of TRIA-662 NCT02008084	Cortria Corporation	Phase 2
Unknown	Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin NCT01956201	Chong Kun Dang Pharmaceutical	Phase 3
Unknown	Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid NCT01974297	Sang Hak Lee	N/A
Completed	A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combi NCT01012219	Merck Sharp & Dohme LLC	Phase 1
Completed	Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia NCT00941603	Merck Sharp & Dohme LLC	Phase 2
Completed	Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) NCT00289900	Merck Sharp & Dohme LLC	Phase 3
Completed	Lipid Efficacy Study (0524B-022)(COMPLETED) NCT00269217	Merck Sharp & Dohme LLC	Phase 3
Terminated	Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvast NCT00134238	Pfizer	Phase 3
Completed	Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care NCT00345657	In His Image	Phase 4